Molecular firms sign European agreement on isotopes

By staff writers

October 18, 2021 -- Israeli radiopharmaceutical firm Isotopia Molecular Imaging and Austria-based Seibersdorf Labor have signed a production agreement for lutetium-177 (Lu-177), which is used to manufacture radioisotopes for cancers including neoendocrine and prostate.

The two firms will collaborate on building a production facility that should be ready by the end of next year. At that facility, Seibersdorf Labor will produce the radiopharmaceutical for European distribution.

Copyright © 2021
Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking